Prognostic factors of choroidal melanoma in Slovenia, 1986–2008
By:
References
- Singh AD, Bergman L, Seregard S. Uveal melanoma: epidemiological aspects. Ophthalmol Clin North Am 2005;18: 75–84.
- Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment and survival. Ophthalmology. 2011; 118: 1881–5.
- Virgili D, Gatta G, Ciccolallo L, Capoccacia R, Biggeri A. Incidence of uveal melanoma in Europe. Ophthalmology 2007; 114: 2309–15.
- Cancer incidence in Slovenia 1983–2009. Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia, 1987–2012.
- Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report No1. Arch Ophthalmol 1990; 108: 1268–73.
- Shields JA, Shields CL. Current management of posterior uveal melanoma. Mayo Clin Proc 1993; 68: 1196–200.
- Shields JA, Shields CL, De Potter P, Singh AD. Diagnosis and treatment of uveal melanoma. Semin Oncol 1996; 23: 763–7.
- Hungerford JL. Management of ocular melanoma. British Medical Bulletin 1995; 51: 694–716.
- Albert DM. The ocular melanoma story, Edward Jackson memorial lecture: Part II. Am J Ophthalmol 1997; 123: 729–41.
- Kertes PJ, Johnson JC, Peyman GA. Internal resection of posterior uveal melanomas. B J Ophthalmol 1998; 82: 1147–53.
- Packer S, Stoller S, Lesser ML, Mandel FS, Finger PT. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology 1992; 99: 767–73.
- Vrabec TR, Augsburger JJ, Gamel JW, Brady LW, Hernandez C, Woodleigh R. Impact of local tumor relapse on patient survival after cobalt 60 plaque radiotherapy. Ophthalmology 1991; 89: 984–8.
- Augsburger JJ, Mullen D, Kleineidam M. Planned combined I 125 plaque irradiation and indirect ophthalmoscope laser therapy for choroidal malignant melanoma. Ophthalmic Surgery 1993; 24: 76–81.
- Papageorgiou KI, Cohen VML, Bunce C, Kinsella M, Hungerford JL. Predicting local control of choroidal melanomas following 106 Ru plaque brachy-therapy. Br J Ophthalmol 2011; 95: 166–70.
- Bercher L, Zografos L, Egger E, Chamot L, Uffer S, Gaillaud C. [Treatment of exterior extension of choroid melanomas by accelerated proton beams]. [French]. Klin Monbl Augenheilkd 1992; 200: 440–3.
- Zografos L, Bercher L, Egger E. [Treatment of eye tumors by accelerated proton beams. 7 years experience]. [French]. Klin Monbl Augenheilkd 1992; 200: 431–5.
- Saornil MJ, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs. enucleated uveal melanomas. Arch Ophthalmol 1992; 110: 1112–8.
- Char DH, Castro JR, Kroll SM, Irvine AR, Quivery JM, Stone RD. Five-year follow-up of helium ion therapy for uveal melanoma. Arch Ophthalmol 1990; 108: 209–14.
- Char DH, Quivery JM, Castro JR, Kroll SK, Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. Ophthalmology 1993; 100: 1547–54.
- Char CH, Kroll SM, Castro J. Ten-year follow-up of helium ion therapy for uveal mela-noma. Am J Ophthalmol 1998; 25: 81–9.
- Damato BE, Paul J, Foulds WS. Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection. Br J Ophthalmol 1996; 80: 102–8.
- Char DH. Clinical ocular oncology. 2nd edition. Philadelphia: Lippincott-Raven Publishers; 1997. p. 114–60.
- Oosterhuis JA, Journee-de Korver HG, Kakebeeke-Kemme HM, Bleeker JC. Transpupillary thermotherapy in choroidal melanomas. Arch Ophthalmol 1995; 113: 315–21.
- Lommatzsch PK. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years experience. Br J Ophthalmol 1986; 70: 844–51.
- Lommatzsch PK. Radiotherapie der intraokularen Tumoren, insbesondere bei Aderhautmelanom. [Experience in treatment of retinoblastoma in the German Democratic Republic]. [German]. Klin Monbl Augenheilkd 1979; 174: 948–58.
- Lommatzsch PK, Werschnik C, Schuster E. Long-term follow-up of Ru-106/ Rh-106 brachytherapy for posterior uveal melanoma. Graefe’s Arch Clin Exp Ophthalmol 2000; 238: 129–37.
- Jančar B. [Choroidal melanoma]. [Slovenian]. Zdrav Vestn 1992; 61: 439–41.
- Novak-Andrejčič K, Logar P, Brovet-Zupančič I, Jančar B. [Treatment of choroidal melanoma with Ru-106 brachytherapy - 14-year experience]. [Slovenian]. Zdrav Vestn 2002; 71(Suppl II): 67–70.
- Solivetti FM, Elia F, Santaguida MG, Guerrisi A, Visca P, Cercato MC, et al. The role of ultrasound and ultrasound-guided fine needle aspiration biopsy of lymph nodes in patients with skin tumours. Radiol Oncol 2014; 48: 29–34.
- The COMS randomized trial of Iodine125 brachytherapy for choroidal melanoma. COMS report No. 28. Arch Ophthalmol 2006; 124: 1684–93.
- Guthoff R, Frischmuth J, Jensen OA. [Choroid melanoma. A retrospective randomized comparative study of ruthenium irradiation vs enucleation]. [German]. Klin Monbl Augenheilkd 1992; 200: 257–61.
- Rouberol F, Roy P, Kodjikian L, Gerard JP, Jean-Louis B. Survival, anatomic and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy. Am J Ophthalmol 2004; 137: 893–900.
- Damato BE, Heimann H, Kalirai H, Coupland SE. Age, survival predictors, and metastatic death in patients with choroidal melanoma: tentative evidence of a therapeutic effect on survival. JAMA Ophthalmol 2014; 132: 605–13.
- Damato B, Coupland SE. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye (Lond) 2009; 23: 2152–60.
- Kujala E, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Kivela T. Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol 2013: 31: 2825–31.
- Shields CL, Furuta M, Thangappan A, Nagori S. Metastasis of uveal melanoma milimeter by milimeter in 8033 consecutive eyes. Arch Ophthalmol 2009; 127: 898–98.
- Damato B. Progress in the management of patients with uveal melanoma. Eye (Lond) 2012; 26: 1157–72.
- Paul EU, Paunell BL, Braker M. Prognostic factors in malignant melanoma of the choroid and ciliary body. Int J Ophthalmol Clin 1962; 2: 387–402.
- Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jöckel KH, Becher R. Prognostic implications of monosomy in uveal melanoma. Lancet 1996; 347: 1222–5.
- Onken MD, Worley LA, Person E, Char DH, Bowcock AM, Harbour JW. Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res 2007; 13: 2923–7.
- Tschentscher F, Prescher G, Zeschnigk M, Horsthemke B, Lohmann DR. Identification of chromosomes 3, 6, and 8 aberrrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet 2000; 122: 13–7.
- Mossbock G, Rauscher T, Winkler P, Kapp KS, Langman G. Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106. Strahlenther Onkol 2007; 10: 571–5.
- Zimmerman L, McLean IW, Foster WD. Does enucleation of the eye containing malignant a melanoma prevent or accelerate the dissemination of malignant cells. Br J Ophthalmol 1978; 62: 420–5.
- Zimmerman L, McLean IW. An evaluation of the enucleation in the management of uveal melanoma. Am J Ophthalmol 1979; 87: 741–60.
- Seddon JM, Gragoudas ES, Egan KM, Polivogianis L. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 1990; 97: 769–77.
- Westphal JR, Hullenaar RV, Geurts-Moespot A, Sweep FC, Verheijen JH, Bussemakers MM. Angiostatin generation by human tumor cell lines. Int J Cancer 2000; 86: 760–7.
- Apte RS, Niederkorn JY, Mayhew E, Alizadeh H. Angiostatin produced by certain primary uveal melanoma cell lines impedes the development of liver metastases. Arch Ophthalmol 2001; 119: 1805–9.
- Grossniklaus HE. Progression of ocular melanoma metastasis to the liver JAMA Ophthalmol 2013; 131: 462–9.
- Kauffman EC, Robinson VL, Stadler WM, Sokoloff MH, Rinker-Schaeffer CW. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol 2003; 169: 1122–33.
- Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No.26. Arch Ophthalmol 2005; 123: 1639–43.
- Straatsma BR, Diener-West M, Caldwell R, Engstrom RE. Mortality after deferral of treatment or no treatment for choroidal melanoma. Am J Ophthalmol 2003; 136: 47–54.
- Damato B. Does ocular treatment of uveal melanoma influence survival. Br J Cancer 2010; 103: 285–90.
Language: English
Page range: 104 - 112
Submitted on: Nov 17, 2014
Accepted on: Dec 9, 2014
Published on: Feb 16, 2016
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2016 Boris Jancar, Marjan Budihna, Brigita Drnovsek-Olup, Katrina Novak Andrejcic, Irena Brovet Zupancic, Dusica Pahor, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.